Maintenance Notice (10:00 PM July 18 - 1:00 AM July 21, 2025 UTC): This website is scheduled to be unavailable due to maintenance. Maintenance may be completed earlier than scheduled. We appreciate your patience and understanding.
Product Document Searching Made Easy by 2D Code! | TCI Materials Science News July 2025 | [Product Highlights] Travoprost with Intra-Ocular-... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
请选择数量
CAS RN: 102518-79-6 | 產品號碼: H1700
產品號碼 | H1700 |
純度/分析方法 ![]() |
>98.0%(HPLC) |
分子式 / 分子量 | C__1__5H__1__8N__2O = 242.32 |
外觀與形狀(20°C) | Solid |
儲存條件 ![]() |
Refrigerated (0-10°C) |
儲存在惰性氣體下 | Store under inert gas |
應避免的情況 | Air Sensitive,Heat Sensitive |
包裝和容器 ![]() |
10MG-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 102518-79-6 |
Reaxys-RN | 3592896 |
PubChem Substance ID | 468591999 |
Merck Index(14) | 4755 |
MDL編號 | MFCD01714949 |
產品規格
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Melting point | 228.0 to 233.0 °C |
Specific rotation [a]20/D | -144 to -155 deg(C=0.5, MeOH) |
Water | max. 3.0 % |
性質
熔點 | 232 °C |
比旋光 [α]D | -147° (C=0.5,MeOH) |
Maximum Wavelength | 313 nm (EtOH) |
GHS
圖形表示 |
![]() |
信號詞 | Danger |
危險性說明 | H300 : Fatal if swallowed. |
防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
相關法規
RTECS # | PB9185700 |
運輸資料
UN編號 | UN1544 |
類別 | 6.1 |
包裝類別 | II |
HS編碼* | 2939.79-000 |
Application
(-)-Huperzine A: A Potent, Highly Specific and Reversible Inhibitor of Acetylcholinesterase
(-)-Huperzine A (HupA), a Lycopodium alkaloid isolated from the Chinese herb Huperzia Serrata, is a potent, highly specific and reversible inhibitor of acetylcholinesterase (AChE). It has been reported that HupA has better penetration through the blood-brain barrier, higher oral bioavailability, and longer duration of AChE inhibitory action, compared with other AChE inhibitors including donepezil [D4099] and rivastigmine [R0093]. Recently, HupA has been used in Alzheimer's disease and other forms of dementia. (The product is for research purpose only.)
References
- The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity
- Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A
- The Lycopodium alkaloids (a review)
- Huperzine A from Huperzia serrata: a review of its sources, chemistry, pharmacology and toxicology
- Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research
- Liquid chromatographic-tandem mass spectrometric method for the quantitation of huperzine A in dog plasma
產品介紹報導
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。